NanoViricides, Inc. (NNVC) stock
NNVCNYSEPharmaceutical PreparationsFiscal year ends June 30
$1.19+0.03 (+2.59%)
Close on Nov 18, 2026Market cap $30.37MP/E –Yield –
NanoViricides revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
NanoViricides's revenue for the twelve months ending Jun 30, 2026 was $0. For fiscal 2026 it was $0.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $0 | – |
| FY2025 | Jun 30, 2025 | $0 | – |
| FY2024 | Jun 30, 2024 | $0 | – |
| FY2023 | Jun 30, 2023 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $0 | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $0 | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $0 | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $0 | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $0 | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $0 | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $0 | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $0 | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $0 | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $0 | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $0 | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $0 | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $0 | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $0 | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $0 | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $0 | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $0 | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $0 | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $0 | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $0 | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $0 | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $0 | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $0 | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $0 | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $0 | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $0 | – |
See a number that looks wrong?